Trial · NCT00438815
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Hereditary Angioedema (HAE) Attacks Treated With C1INH-nf | Open-label C1INH-nf | Conservative Analysis | 609 | attacks | |
| Number of Hereditary Angioedema (HAE) Attacks Treated With C1INH-nf | Open-label C1INH-nf | Less Conservative Analysis | 598 | attacks | |
| Time to Beginning of Substantial Relief of the Defining Symptom | Open-label C1INH-nf | 0.75 | 95% Confidence Interval 0.50 to 1.00 | hours | |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 1 | 1.50 | 95% Confidence Interval 0.75 to 4.00 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 2 | 0.50 | 95% Confidence Interval 0.25 to 2.50 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 3 | 0.50 | 95% Confidence Interval 0.50 to 0.75 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 4 | 0.50 | 95% Confidence Interval 0.25 to 1.00 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 5 | 0.75 | 95% Confidence Interval 0.50 to 1.25 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 6 | 0.50 | 95% Confidence Interval 0.25 to 1.25 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 7 | 0.75 | 95% Confidence Interval 0.50 to 0.75 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 8 | 0.50 | 95% Confidence Interval 0.25 to 0.75 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 9 | 0.25 | 95% Confidence Interval 0.25 to 0.50 | hours |
| Time to Beginning of Substantial Relief of the Defining Symptom for Subjects Who Received Multiple Treatments | Open-label C1INH-nf | Attack number 10 | 0.50 | 95% Confidence Interval 0.25 to 0.75 | hours |
| Antigenic C1 Inhibitor (C1INH) Serum Levels | Open-label C1INH-nf | Pre-infusion | 10.7 | Standard Deviation 13.91 | mg/dL |
| Antigenic C1 Inhibitor (C1INH) Serum Levels | Open-label C1INH-nf | Increase at 1 hour post-infusion | 9.6 | Standard Deviation 12.98 | mg/dL |
| Functional C1INH Serum Levels | Open-label C1INH-nf | Pre-infusion | 27.0 | Standard Deviation 19.30 | percent of functional C1INH |
| Functional C1INH Serum Levels | Open-label C1INH-nf | Percent increase at 1 hour post-infusion | 39.2 | Standard Deviation 18.04 | percent of functional C1INH |
| Complement C4 Serum Levels | Open-label C1INH-nf | Pre-infusion | 5.3 | Standard Deviation 5.41 | mg/dL |
| Complement C4 Serum Levels | Open-label C1INH-nf | Change at 1 hour post-infusion | -0.2 | Standard Deviation 1.51 | mg/dL |
| Percent of HAE Attacks With Substantial Relief of the Defining Symptom | Open-label C1INH-nf | Conservative Analysis | 87 | percent of attacks |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00438815/results